(Q46470298)

22 December 2017

title

Proton MRS in twin pairs discordant for schizophrenia (English)

1 reference

22 December 2017

0 references

4

1 reference

22 December 2017

Jaakko Kaprio

7

1 reference

22 December 2017

Marko Manninen

object named as

M Manninen

5

0 references

author name string

E S Lutkenhoff

1

1 reference

22 December 2017

T G van Erp

2

1 reference

22 December 2017

M A Thomas

3

1 reference

22 December 2017

M O Huttunen

6

1 reference

22 December 2017

J Lönnqvist

8

1 reference

22 December 2017

J O'Neill

9

1 reference

22 December 2017

T D Cannon

10

1 reference

22 December 2017

language of work or name

English

0 references

publication date

22 July 2008

1 reference

22 December 2017

published in

Molecular Psychiatry

1 reference

22 December 2017

volume

15

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

308-318

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1038/mp.2008.87

exact match

0 references

cites work

The relationship between performance and fMRI signal during working memory in patients with schizophrenia, unaffected co-twins, and control subjects.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Hippocampal volumes in schizophrenic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

The inheritance of neuropsychological dysfunction in twins discordant for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Brain Damage Results in Down-Regulation of N-Acetylaspartate as a Neuronal Osmolyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Decrease and recovery of N-acetylaspartate/creatine in rat brain remote from focal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Postmortem degradation of N-acetyl aspartate and N-acetyl aspartylglutamate: an HPLC analysis of different rat CNS regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Magnetic resonance spectroscopy of neurotransmitters in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

21 January 2018

ATP and brain function

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Back in the water: the return of the inositol phosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Magnetic resonance spectroscopy in schizophrenia. Possibilities and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Proton magnetic resonance spectroscopy of the frontal lobe in schizophrenics: a critical review of the methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Preliminary study of frontal lobe 1H MR spectroscopy in childhood-onset schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

NMDA receptor hypofunction model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

The membrane hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Quantitative proton-decoupled 31P MRS of the schizophrenic brain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Magnetic resonance imaging and spectroscopy in offspring at risk for schizophrenia: preliminary studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

In vitro 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Glutamate receptor dysfunction and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Genetic and environmental factors in complex diseases: the older Finnish Twin Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Cramér-Rao bounds: an evaluation tool for quantitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Elevated 3T proton MRS glutamate levels associated with poor Continuous Performance Test (CPT-0X) scores and genetic risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Evidence for neuronal dysfunction in the anterior cingulate of patients with schizophrenia: a proton magnetic resonance spectroscopy study at 3 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Sensitivity of single-voxel 1H-MRS in investigating the metabolism of the activated human visual cortex at 7 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Single-voxel 1H PRESS at 4.0 T: precision and variability of measurements in anterior cingulate and hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Proton echo-planar spectroscopic imaging of J-coupled resonances in human brain at 3 and 4 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Advances in functional and structural MR image analysis and implementation as FSL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Neurotransmitter interactions in schizophrenia--therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Quantitative proton MR spectroscopic imaging of the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Creatine deficiency in the brain: a new, treatable inborn error of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Decreased left frontal lobe N-acetylaspartate in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders--focus on magnetic resonance spectroscopy (MRS) studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Proton magnetic resonance spectroscopy (1H MRS) in schizophrenia: investigation of the right and left hippocampus, thalamus, and prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Proton magnetic resonance spectroscopy (1H-MRS) of the thalamus in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Lithium effects on brain glutamatergic and GABAergic systems of healthy volunteers as measured by proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Association between cerebral glutamate and human behaviour: the sensation seeking personality trait.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

7 January 2021

Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

7 January 2021

Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

7 January 2021

In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

7 January 2021

Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

7 January 2021

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

7 January 2021

Quantitative analysis of short echo time1H-MRSI of cerebral gray and white matter

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

7 January 2021

Magnetic resonance spectroscopy for monitoring neuronal integrity in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

7 January 2021

Frontolimbic glutamate alterations in first episode schizophrenia: evidence from a magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

7 January 2021

Quantitation of NAA in the brain by magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

7 January 2021

Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.87

7 January 2021

Identifiers

DOI

10.1038/MP.2008.87

1 reference

22 December 2017

release_lxxasgsvnfdz3ccnk5g2h4kiye

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lxxasgsvnfdz3ccnk5g2h4kiye

24 November 2022

mapped directly with Wikidata item

PubMed ID

18645571

1 reference

22 December 2017